Mara Aspinall is a healthcare industry leader, and serves as the President and CEO of Health Catalysts, and the Executive Chairman of GenePeeks.
Aspinall has held President and CEO roles for Ventana Medical Systems, Genzyme Genetics and Genzyme Pharmaceuticals, and On-Q- ity, a start-up diagnostic company dedicated to circulating tumor cells.
Recently, Aspinall spearheaded initiatives to educate payers and policymakers on genomics and personalized medicine. She served as an active member of the Health and Human Services Secretary’s Advisory Council on Genetics, in both the Obama and Bush administrations.
Aspinall is the Chair of the Arizona Biosciences Board, and serves on several addition boards including 3Scan, Abcam, Allscripts Healthcare Solutions, AZBio, Castle Biosciences, Blue Cross Blue Shield Arizona, and OraSure Technologies.
Lastly, she holds an MBA from Harvard Business School, and a BA in International Relations from Tufts University.